June 12, 2024

Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease – Nature.com

May 14, 2024

Study defines major genetic form of Alzheimer’s disease – National Institutes of Health (NIH) (.gov)

May 6, 2024

APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease – Nature.com

November 14, 2022

Experimental therapy gantenerumab fails to slow or improve Alzheimer’s memory loss in clinical trials

An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.